Arthur Tso

Advising CMC Capital Partners on investments in Cloud Music (HKEx: 9899), Chongqing Hongjiu Fruit (HKEx: 6689), Star CM (HKEx: 6698) and Ourgame (HKEx: 6899).

Advising Lilly Asia Venture, the corporate venture capital arm of Eli Lilly (NYSE: LLY), on investments in Abbisko Cayman (HKEx: 2256) and Peijia Medical Limited (HKEx: 9996).

Advising Nall Technology LP on subscription of pre-IPO convertible promissory notes issued by Smoore International (HKEx: 6969).

Advising Ark Pacific Capital on investment in convertible note of a plant-based meat company.

Advising CEL Dynamic Growth Fund, a subsidiary of China Everbright, on strategic investment in a U.S. SPAC.

Advising Matrix Partners, IHH Healthcare (5225.KL) and Jade Road Investments on several pre-IPO investments.

Advising Borqs Technologies Inc. (Nasdaq: BORQS), a leading Internet of Things (IoT) platform solution provider, on its sale of software design and customised hardware manufacturing businesses to Sasken Technologies Limited (NSE: SASKEN) for a maximum consideration of US$40 million.

Advising Winner Medical (SHE: 300888) as buyer on proposed acquisition of a medical device company in England.

Advising Tibet 5100 Water (HKEx: 1115) as buyer on RMB600 million acquisition of Tibet Highland Natural Water, and US$180 million acquisition of Tibet Tiandi Green Beverage.

Advising Winteam Pharmaceutical (HKEx: 0570) as buyer on RMB2.6 billion acquisition of Tongjitang Chinese Medicine.

Advising Accenture as buyer on its US$316 million acquisition of Acquity Group (NYSE: AQ).

Advising Sun Materials Technology as seller on the US$150 million sale of 50.1% interest in a solar grade polycrystalline silicon manufacturing business to Mascotte Holdings (HKEx: 0136).

Advising Sun Capital Partners as buyer on its acquisition of China-based ZhongShan Meiquan Plastic Products.

Advising Mason Group (HKEx: 0273) as offeree on a HK$1.5 billion privatisation by way of a Hong Kong scheme of arrangement.

Advising a controlling shareholder as offeror on the mandatory general offer of a Hong Kong listed company in the metals and mining sector.

Advising Delta Networks, Inc. (HKEx: 0722) as offeree on a HK$1.1 billion privatisation by Delta Electronics by way of a Cayman Islands scheme of arrangement.

Advising a Hong Kong listed company in the food and beverage sector as offeree on a mandatory general offer.

Advising a French cardboard games company as offeror on the potential privatisation of a Hong Kong listed company by way of a Cayman Islands scheme of arrangement.

Advising various Hong Kong listed companies on submissions to the SFC on Takeovers Code matters, including whitewash waiver applications and submissions to rebut acting-in-concert presumptions.

Advising various founders and majority shareholders of Hong Kong listed companies on privatisation proposals.

Arthur has acted as issuer’s counsel, underwriters’ counsel and/or counsel to controlling shareholders and key investors on a number of high profile Hong Kong IPOs, including primary and secondary listings, across a variety of industries, including:

Advising clients in the emerging technologies sector on listings and IPOs:

• Cloud Music Inc (HKEx: 9899)
• Tongdao Liepin (HKEx: 6100)
• Tongcheng Travel (HKEx: 0780)
• Dida Inc (HKEx: 2559)
• Meitu Inc. (HKEx: 1357)

Representing controlling/major shareholders or institutional investors.

Advising clients in the entertainment and media sector on listings and IPOs:

• STAR CM Holdings (HKEx: 6698)
• iDreamSky Technology (HKEx: 1119)
• China Mobile Games (HKEx: 0302)
• Ourgame (HKEx: 6899)
• Boyaa (HKEx: 0434)
• Tian Ge Interactive (HKEx: 1980)
• Feiyu (HKEx: 1022)
• Wynn Macau (HKEx: 1128)

Representing controlling/major shareholders or institutional investors.

Advising clients in the financial services sector on listings and IPOs:

• Lufax Holding (NYSE: LU; HKEx: 6623)
• China Huarong Asset Management (HKEx: 2799)
• SBI Holdings (HKEx: 6488-DRS)

Representing controlling/major shareholders or institutional investors.

Advising clients in the health care sector on listings and IPOs:

• Yunkang Group (HKEx: 2325)
• Wenzhou Kangning Hospital (HKEx: 2120)
• Sinco Pharma (HKEx: 6833)
• EDDA Healthcare (LSE: 810238)

Advising clients in the biotechnology sector on listings and IPOs:

• Everest Medicines (HKEx: 1952-B)
• Suzhou Basecare Medical (HKEx: 2170-B)
• Genor Biopharma (HKEx: 6998-B)
• Peijia Medical (HKEx: 9996-B)
• Abbisko Cayman (HKEx: 2256-B)

*Representing controlling/major shareholders or institutional investors.

Advising clients in the retail and consumer goods sector on listings and IPOs:

• Nayuki Holdings (HKEx: 2150)
• Greentown Management (HKEx: 9979)
• Chongqing Hongjiu Fruit (HKEx: 6689)
• Smoore International (HKEx: 6969)
• China Harmony Auto (HKEx: 3836)
• NVC Lighting Holding (HKEx: 2222)
• Tibet 5100 Water Resources (HKEx: 1115)

*Representing controlling/major shareholders or institutional investors.

Advising clients in the energy and natural resources sector on listings and IPOs:

• China Gold International (HKEx: 2099; TSX: CGG)
• CITIC Dameng (HKEx: 1091)
• SouthGobi Resources (TSX: SGQ; HKEx: 1878-S)
• Kazakhmys PLC (LSE: KAZ; HKEx: 0847-S)
• Sunshine Oilsands (HKEx: 2012)
• Yangtze Optical Fibre and Cable (HKEx: 6869)
• Mongolia Mining (HKEx: 0975)
• Nanjing Hanrui (SHE: 300618)
• Heaven-Sent Gold

Advising clients in the transportation and infrastructure sector on listings and IPOs:

• Chengdu Expressway (HKEx: 1785)
• China Railway Signal & Communications (HKEx: 3969; SSE: 688009)
• China ITS (Holdings) (HKEx: 1900)
• SITC International (HKEx: 1308)
• Qinhuangdao Port (HKEx: 3369; SSE: 601326)

*Representing controlling/major shareholders or institutional investors.

Advising the underwriters on the issuance of US$600 million 1.875% senior notes by Want Want China Finance Limited, guaranteed by Want Want China (HKEx: 0151).

Advising Tibet 5100 Water Resources (HKEx: 1115) on its issuance of 6% convertible bonds with a principal amount of HK$525 million.

Advising iDreamSky Technology (Nasdaq: DSKY; HKEx: 1119) on its subscription of HK$20 million 4% convertible bonds issued by China Partytime Culture Holdings Limited (HKEx: 1532).

Advising Shenzhen Expressway (HKEx: 0548) on its issuance of US$300 million 2.875% investment grade bonds listed on the Hong Kong Stock Exchange.

Advising CITIC Capital China Access Fund Limited on its subscription of HK$232.8 million 3.5% convertible bonds issued by China Tianyi Holdings Limited (HKEx: 0756).